Comparative study on the stem cell phenotypes of C6 cells under different culture conditions

Chinese Medical Journal

Volumn 124, Issue 19, 2011, Pages 3118-3126

  Zhang, Suo Jun ^a   Ye, Fei ^a   Xie, Rui Fan ^a   Hu, Feng ^a   Wang, Bao Feng ^a   Wan, Feng ^a   Guo, Dong Sheng ^a   Lei, Ting ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

C6; CD133; Glioma stem cell; Laminin; Neurosphere; Side population

Indexed keywords

BETA TUBULIN; CD133 ANTIGEN; EOSIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; LAMININ; NESTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENICITY; CELL ADHESION; CELL ASSAY; CELL CYCLE; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRAIN; CELL STRAIN C6; CELL SUSPENSION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; FEMALE; FLOW CYTOMETRY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SURVIVAL TIME; WESTERN BLOTTING;

ANIMALS; CULTURE MEDIA; GLIOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 80053471856     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.19.030     Document Type: Article

References (26)

1. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-9344.
2. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006; 6: 425-436.
3. Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, et al. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol 2009; 94: 1-19.
4. Fu J, Liu ZG, Liu XM, Chen FR, Shi HL, Pangjesse CS, et al. Glioblastoma stem cells resistant to temozolomide-induced autophagy. Chin Med J 2009; 122: 1255-1259.
5. Hua W, Yao Y, Chu Y, Zhong P, Sheng X, Xiao B, et al. The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma. J Neurooncol 2011; Epub ahead of print.
6. Niu CS, Li DX, Liu YH, Fu XM, Tang SF, Li J. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells. Oncol Rep 2011; 26: 593-601.
7. Fan H, Guo H, Zhang IY, Liu B, Luan L, Xu S, et al. The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251. Brain Res 2011; 1384: 9-14.
8. Inoue A, Takahashi H, Harada H, Kohno S, Ohue S, Kobayashi K, et al. Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity. Int J Oncol 2010; 37: 1121-1131.
9. Zheng X, Shen G, Yang X, Liu W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 2007; 67: 3691-3697.
10. Wan F, Zhang S, Xie R, Gao B, Campos B, Herold-Mende C, et al. The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol 2010; 20: 877-889.
11. Reynolds BA, Rietze RL. Neural stem cells and neurospheres - re-evaluating the relationship. Nat Methods 2005; 2: 333-336.
12. Chaichana K, Zamora-Berridi G, Camara-Quintana J, Quinones-Hinojosa A. Neurosphere assays: growth factors and hormone differences in tumor and nontumor studies. Stem Cells 2006; 24: 2851-2857.
13. Chaichana KL, Guerrero-Cazares H, Capilla-Gonzalez V, Zamora-Berridi G, Achanta P, Gonzalez-Perez O, et al. Intra-operatively obtained human tissue: protocols and techniques for the study of neural stem cells. J Neurosci Methods 2009; 180: 116-125.
14. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996; 175: 1-13.
15. Suslov ON, Kukekov VG, Ignatova TN, Steindler DA. Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres. Proc Natl Acad Sci U S A 2002; 99: 14506-14511.
16. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009; 4: 568-580.
17. Reynolds BA, Vescovi AL. Brain cancer stem cells: think twice before going flat. Cell Stem Cell 2009; 5: 466-467; author reply 468-469.
18. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16: 2715-2728.
19. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
20. Carlsson J, Acker H. Relations between pH, oxygen partial pressure and growth in cultured cell spheroids. Int J Cancer 1988; 42: 715-720.
21. Bell HS, Whittle IR, Walker M, Leaver HA, Wharton SB. The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems. Neuropathol Appl Neurobiol 2001; 27: 291-304.
22. Meeson AP, Hawke TJ, Graham S, Jiang N, Elterman J, Hutcheson K, et al. Cellular and molecular regulation of skeletal muscle side population cells. Stem Cells 2004; 22: 1305-1320.
23. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 2004; 101: 781-786.
24. Angelastro JM, Lame MW. Overexpression of CD133 promotes drug resistance in C6 glioma cells. Mol Cancer Res 2010; 8: 1105-1115.
25. Zhou XD, Wang XY, Qu FJ, Zhong YH, Lu XD, Zhao P, et al. Detection of cancer stem cells from the C6 glioma cell line. J Int Med Res 2009; 37: 503-510.
26. Shen G, Shen F, Shi Z, Liu W, Hu W, Zheng X, et al. Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods. In Vitro Cell Dev Biol Anim 2008; 44: 280-289.